 Home > Active Ingredient News > Antitumor Therapy > A prospective multi-center clinical study on the differential diagnosis of benign and malignant pulmonary nodules based on multi-omics | Live Preview

A prospective multi-center clinical study on the differential diagnosis of benign and malignant pulmonary nodules based on multi-omics | Live Preview

 Last Update: 2021-04-22
 Source: Internet
 Author: User

Tags

cla 10

pna medical diagnosis

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The morbidity and mortality of lung cancer are both in the first place among malignant tumors in my country.

According to statistics, the proportion of people at high risk of lung cancer in the Chinese population accounts for more than 20% of the overall population, and the incidence of pulmonary nodules in the high-risk population of lung cancer reaches 35.

More than 95% of small lung nodules are benign nodules.

MISSION ( M ULTI-OM the I cs CLA SSI Fier for Pulm O nary N odules) program by the Shanghai Pulmonary Hospital to participate in a number of other 10 hospitals nationwide , initiated by Taylor bio-led, designed to take advantage of multi-omics technologies ( Metabolome, proteome, epigenetics, imaging group), a prospective multi-center clinical research project for the differential diagnosis of benign and malignant pulmonary nodules in patients with small lung nodules (≤3cm) on medical images .

The MISSION plan will be carried out in two phases.

The launching ceremony of the prospective multi-center clinical study on the differential diagnosis of benign and malignant pulmonary nodules based on multi-omics will be live broadcast online at 15:30 pm on April 18th .

Click to watch this live broadcast

Click to watch this live broadcast and leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.